Hybrid Program | 8.75 CE/CME Credits & MOC Points

All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.

The 3rd Annual Best of Hematology Conference is an innovative and state-of-the-art program that features some of the world's leading hematologists presenting the latest research and strategies for the care of hematological malignancies — incorporating data from the major oncologic annual meetings.

Conference Agenda
Saturday, February 7th, 2026

7:30 AM
Coffee and Exhibits

8:00 AM
Welcome and Opening Remarks

8:10 AM
Targeted and MRD-Driven Approaches in Acute Leukemia
Mat Angelos, MD | University of Colorado Cancer Center

8:40 AM
Chronic Leukemia: Targetable Pathways in CLL
Bita Fakhri, MD | Stanford University School of Medicine
9:10 AM
Breakfast and Exhibits

9:25 AM
Non-CME Breakfast

10:10 AM
Moving Beyond R-CHOP in DLBCL
Micheal Tees, MD, MPH | Colorado Blood Cancer Institute

10:40 AM
Indolent Lymphoma: Strategies for Personalizing Long-Term Care
Ann S. LaCasce, MD | Dana-Farber Cancer Institute

11:10 AM
Lunch and Exhibits

11:25 AM
Non-CME Lunch

12:10 PM
Housekeeping and Survey

12:20 PM
Extended Panel Discussion: Game-Changing Results from 2025 – What Will Be the Impact on Current Practice?
Mat Angelos, MD | University of Colorado Cancer Center
Bita Fakhri, MD |Stanford University School of Medicine
Micheal Tees, MD | Colorado Blood Cancer Institute
Anne S. LaCasce, MD | Dana-Farber Cancer Institute

1:20 PM
Adjourn

Sunday, February 8th, 2026

7:30 AM
Coffee and Exhibits

8:00 AM
Welcome and Opening Remarks

8:10 AM
Bispecifics, CAR-T Cells, and Sequencing Strategies in Multiple Myeloma
Jorge Monge, MD | University of Colorado Cancer Center

8:40 AM
What's New in the T-Cell and Rare Lymphomas?
Bradley Haverkos, MD | University of Colorado

9:10 AM
Breakfast and Exhibits

9:25 AM
Non-CME Breakfast

10:10 AM
Myeloproliferative Disorders
Naveen Pemmaraju, MD | MD Anderson Cancer Center

10:40 AM
Sickle Cell Disease & Thalassemia: Gene Therapy and Novel Approaches
Elizabeth Traxler, MD | Perelman School of Medicine at University of Pennsylvania

11:10 AM
Lunch and Exhibits

11:25 AM
Non-CME Lunch

12:10 PM
Housekeeping and Survey

12:20 PM
Extended Panel Discussion: How and When Do You Integrate Novel Therapies into Practice?
Naveen Pemmaraju, MD | MD Anderson Cancer Center
Jorge Monge, MD | University of Colorado Cancer center
Bradley Haverkos, MD | University of Colorado
Elizabeth Traxler, MD | Perelman School of Medicine at University of Pennsylvania

1:20 PM
AJOURN

Agenda Subject To Change. All times are MST.

• Learning Objectives

  • Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various hematologic malignancies.

  • Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with hematologic malignancies.

  • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with hematologic malignancies.

• Accreditation Information | 8.75 CE/CME Credits & MOC Points

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 8.75 ANCC contact hours.

  Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 8.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 8.75 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

  American Board of Internal Medicine (ABIM) MOC Credit

  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

• What to Expect

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources